Evolent Health SEC filings
Filter: All · 8-K · 10-Q · 10-K · Form 4
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedEvolent Health Q3 2026 revenue of $725.4 million up 51% year over year, adjusted EPS $0.06 in line with consensus; Adjusted EBITDA guidance raised to $130.0-$135.0 million
Results of operations and financial condition · Financial statements and exhibits